Sapovirus .. also to keep in mind like Norovirus 🤮🤢
Yahoo News
Johns Hopkins Medicine
Johns Hopkins Gastroenterology & Hepatology
#GITwitter

#HITEC2024 registration is NOW OPEN! Scan the QR code below to secure your spot to join us in #Baltimore this September. We hope to see you there! #endoscopy #gastroenterology

ASGE GI Endoscopy Johns Hopkins Gastroenterology & Hepatology Johns Hopkins Medicine HopkinsCME Saowanee Ngamruengphong

ICU Hepatology Update:

If you feel a bit queasy - I feel the same! - whenever you admit a patient with cirrhosis/acute-on-chronic liver failure (ACLF), you will find useful this excellent document from the American Association for the Study of Liver Diseases (AASLD):

#MASLD ( #NAFLD ) & alcohol-related liver disease share pathophysiological features and are leading causes of chronic liver disease worldwide

Find out more about their intersection & management in this REVIEW
rdcu.be/dFbG2
#WorldLiverDay

Happy #WorldLiverDay ! It's a hepatology takeover today so we can #StepUpForLiverHealth

Starting with this Consensus Statement that calls for action to advance the global public health agenda for #NAFLD / #MASLD
nature.com/articles/s4157…

This week's most cited article:

#ColorectalCancer in Inflammatory Bowel Disease: Mechanisms and Management -- ow.ly/KavU50R9zbA

Shailja Shah, MD MPH UC San Diego Mount Sinai Health System

#IBD #CrohnsDisease #UlcerativeColitis

Great graphic! Super helpful! #GITwitter Kavin Kanthasamy Merve Gurakar, MD MPH Lea Fayad Ernesto Robalino Gonzaga, MD. Jessica El Halabi Robert Hughes, MD PhD Robyn Jordan Eric Moughames

1/8
You are rotating on the Procedure Service and your team is asked to perform a routine “therapeutic” paracentesis on a patient with cancer. You walk into the room to meet the patient and this is what you see.

This finding should generate a hypothesis.

Today, FDA approved a medication for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), to be used along with diet and exercise. fda.gov/news-events/pr…

Today I am thrilled that we finally get to share this case with the world via NEJM. Much thanks to Caoilfhionn Connolly (fellow member of the #FirmofGiants ) and Allan Gelber (a giant in his own right) for including me in the care of this patient. The Osler Medical Residency

This is the scariest thing I’ve read in, maybe ever

Incredible work in NEJM

nejm.org/doi/full/10.10…

ERAS should limit the number of publications an applicant can list to five and instruct applicants to list their five most important. This would help prioritize meaningful research contributions on a few projects and disincentivize the current arms race of publication padding.

Implementation of FIB-4 is very important to screen high risk #MASLD population but data from our group and W Ray Kim emphasizes that we need to continue improving the tests/process #livertwitter CGH pubmed.ncbi.nlm.nih.gov/38428706/

Excited to be presenting an abstract on demographics in patients with CPUE at Digestive Disease Week this year, thanks to the excellent guidance from Dr. Zach Foda (@HopkinsGIHep) See you in Washington DC! American Gastroenterological Association (AGA) The Osler Medical Residency #ddw2024

Congrats to IM resident Dr. Sanjana Verma The Osler Medical Residency!
She will work with us on a unique cohort study Johns Hopkins Bloomberg School of Public Health to better our understanding of #Alcohol and its impact on liver disease.
ACG Johns Hopkins Gastroenterology & Hepatology

Seen at #ECCO24 #ECCO2024 this Figure on potential adverse effects of JAK inhibition for #IBD

Paper here: nature.com/articles/s4157…
Free to read rdcu.be/dzo8l

Hot off the Press: The Most Important MASH phase 3 RCT hopefully leading to first Drug approval for MASH is out #livertwitter nejm.org/doi/full/10.10…

NEW! This Figure shows an overview of glucose metabolic pathways in the hepatocyte.

Find out more about hepatic glucose metabolism in the steatotic liver here nature.com/articles/s4157…

#NAFLD #MASLD